deepeye Medical GmbH

deepeye Medical GmbH specializes in AI-assisted medical devices for ophthalmology. Currently, the company produces the deepeye® TPS, a system designed to assist clinicians in planning therapies for retinal diseases. This device helps optimize treatment strategies for conditions like age-related macular degeneration and diabetic retinopathy by leveraging artificial intelligence.

deepeye Medical GmbH is based in Germany. The company focuses on advancing ophthalmology through innovative technology, specifically developing AI-driven tools like the deepeye® TPS to improve therapy planning for retinal diseases. This aligns with its goal of enhancing patient care and clinical efficiency in specialized eye care.

The deepeye® TPS is listed in the eudamed database, which is the European Union’s central registry for medical devices. This registration ensures transparency and compliance with EU requirements for Class IIa devices, though it does not imply regulatory approval—only that the device is documented in the official system.

The deepeye® TPS falls under Class IIa classification in the EU medical device regulatory framework. This classification is determined by factors like the device’s intended purpose, risk level, and potential impact on patient safety. Class IIa devices are considered moderate-risk and require compliance with specific design controls and clinical evaluations before market placement.